Literature DB >> 28266673

Comparative pharmacokinetic profile of cyclosporine (CsA) with a decapeptide and a linear analogue.

David A Price1, Heather Eng, Kathleen A Farley, Gilles H Goetz, Yong Huang, Zhaodong Jiao, Amit S Kalgutkar, Natasha M Kablaoui, Bhagyashree Khunte, Spiros Liras, Chris Limberakis, Alan M Mathiowetz, Roger B Ruggeri, Jun-Min Quan, Zhen Yang.   

Abstract

The synthesis and in vivo pharmacokinetic profile of an analogue of cyclosporine is disclosed. An acyclic congener was also profiled in in vitro assays to compare cell permeability. The compounds possess similar calculated and measured molecular descriptors however have different behaviors in an RRCK assay to assess cell permeability.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28266673     DOI: 10.1039/c7ob00096k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  4 in total

1.  Permeability of Cyclic Peptide Macrocycles and Cyclotides and Their Potential as Therapeutics.

Authors:  Spiros Liras; Kim F Mcclure
Journal:  ACS Med Chem Lett       Date:  2019-06-14       Impact factor: 4.345

2.  Understanding Cell Penetration of Cyclic Peptides.

Authors:  Patrick G Dougherty; Ashweta Sahni; Dehua Pei
Journal:  Chem Rev       Date:  2019-05-14       Impact factor: 60.622

3.  Ring Size as an Independent Variable in Cyclooligomeric Depsipeptide Antiarrhythmic Activity.

Authors:  Abigail N Smith; Daniel J Blackwell; Bjorn C Knollmann; Jeffrey N Johnston
Journal:  ACS Med Chem Lett       Date:  2021-11-23       Impact factor: 4.345

Review 4.  Improvement on Permeability of Cyclic Peptide/Peptidomimetic: Backbone N-Methylation as A Useful Tool.

Authors:  Yang Li; Wang Li; Zhengshuang Xu
Journal:  Mar Drugs       Date:  2021-05-27       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.